Description
Product details
ROUSTRIN AV 20 Rosuvastatin (20mg), Aspirin (75mg) ROUSTRIN AV 20 is a common strategy for managing cardiovascular risk and preventing cardiovascular events. Here's a detailed look at how ROUSTRIN AV 20 work , its benefits, and important considerations. Rosuvastatin Class: Statin (HMG-CoA reductase inhibitor) Primary Use: Lowers levels of "bad" cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood, while increasing "good" cholesterol (high-density lipoprotein, or HDL). This action helps reduce the risk of atherosclerosis (plaque buildup in the arteries) and cardiovascular events such as heart attacks and strokes. Mechanism: Inhibits the enzyme HMG-CoA reductase in the liver, decreasing the production of cholesterol. Side Effects: May include muscle pain, headache, nausea, and increased risk of diabetes. Serious but rare side effects include muscle breakdown (rhabdomyolysis) and liver damage. Aspirin Class: Nonsteroidal anti-inflammatory drug (NSAID) with antiplatelet properties at low doses. Primary Use: At low doses, aspirin is used to prevent blood clots, reducing the risk of heart attacks and strokes in individuals with cardiovascular disease or those at high risk. Mechanism: Aspirin inhibits the cyclooxygenase (COX) enzyme, leading to reduced production of thromboxane A2, a molecule that promotes platelet aggregation and vasoconstriction. Side Effects: Can include gastrointestinal bleeding, ulcers, and, in rare cases, hemorrhagic stroke, especially at higher doses. ROUSTRIN AV 20 Rationale: ROUSTRIN AV 20 used to address both cholesterol management and platelet aggregation, tackling two major factors in cardiovascular disease. Rosuvastatin reduces cholesterol and thereby the risk of plaque formation, while aspirin prevents platelet clumping, reducing the risk of clot formation that can lead to heart attacks or strokes. Benefits: ROUSTRIN AV 20 is particularly beneficial for individuals at high risk of cardiovascular events, offering a dual approach to prevention. Monitoring: Patients using this combination should be monitored for potential side effects, such as muscle symptoms from rosuvastatin and bleeding risks from aspirin. Regular blood tests to monitor liver function and lipid levels may be necessary. Considerations: It's important for healthcare providers to evaluate the benefits and risks of this combination based on individual patient factors. For example, the risk of gastrointestinal bleeding with aspirin may be more significant in some patients, requiring careful consideration or additional protective measures such as the use of proton pump inhibitors. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 BUY NOW https://www.sterisonline.com/product/roustrin-av-20-133363
